Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma
- PMID: 26003625
- DOI: 10.1016/j.urolonc.2015.01.010
Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma
Abstract
Aims: PBRM1 is one of the histone and chromatin regulators. A mutation in PBRM1 was recently identified in clear cell renal cell carcinoma (ccRCC). The aim of this study was to determine the clinicopathologic and prognostic significance of PBRM1 expression in ccRCC.
Methods and results: Immunohistochemistry was performed for PBRM1 in 657 ccRCC cases. The number of positive cells was determined using image analyzer after virtual microscope scanning. There was a strong correlation between decreased PBRM1 expression and old age, increased tumor size, higher Fuhrman grade, higher pT stage, and higher stage (all P <0.001). Patients with decreased PBRM1 expression showed significantly worse cancer-specific survival (CSS) and progression-free survival (PFS) (both P<0.001). In multivariate analysis, PBRM1 expression was an independent predictor of shorter PFS (P = 0.007). In lower-stage group (stages I and II), decreased expression of PBRM1 exhibited significantly worse CSS and PFS (both P<0.001) but not in higher-stage group (stages III and IV). In multivariate analysis of lower-stage group, decreased expression of PBRM1 was significantly associated with both poor CSS and PFS (P = 0.038 and 0.003, respectively).
Conclusions: Decreased expression of PBRM1 predicts unfavorable clinical outcome in patients with ccRCC.
Keywords: Carcinoma; Immunohistochemistry; Kidney; PBRM1; Prognosis; Renal cell.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival.Urol Oncol. 2018 Mar;36(3):94.e1-94.e14. doi: 10.1016/j.urolonc.2017.10.027. Epub 2017 Nov 21. Urol Oncol. 2018. PMID: 29169846
-
Loss of PBRM1 expression is associated with renal cell carcinoma progression.Int J Cancer. 2013 Jan 15;132(2):E11-7. doi: 10.1002/ijc.27822. Epub 2012 Oct 3. Int J Cancer. 2013. PMID: 22949125
-
Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma.BJU Int. 2014 May;113(5b):E157-63. doi: 10.1111/bju.12426. Epub 2013 Dec 2. BJU Int. 2014. PMID: 24053427
-
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.Nat Rev Nephrol. 2021 Apr;17(4):245-261. doi: 10.1038/s41581-020-00359-2. Epub 2020 Nov 3. Nat Rev Nephrol. 2021. PMID: 33144689 Free PMC article. Review.
-
BAF180: Its Roles in DNA Repair and Consequences in Cancer.ACS Chem Biol. 2017 Oct 20;12(10):2482-2490. doi: 10.1021/acschembio.7b00541. Epub 2017 Sep 28. ACS Chem Biol. 2017. PMID: 28921948 Review.
Cited by
-
New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review).Int J Oncol. 2023 Jul;63(1):86. doi: 10.3892/ijo.2023.5534. Epub 2023 Jun 16. Int J Oncol. 2023. PMID: 37326100 Free PMC article. Review.
-
The convergence of tumor suppressors on the type I interferon pathway in clear cell renal cell carcinoma and its therapeutic implications.Am J Physiol Cell Physiol. 2022 Nov 1;323(5):C1417-C1429. doi: 10.1152/ajpcell.00255.2022. Epub 2022 Sep 26. Am J Physiol Cell Physiol. 2022. PMID: 36154696 Free PMC article. Review.
-
PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma.Cancers (Basel). 2022 Feb 20;14(4):1062. doi: 10.3390/cancers14041062. Cancers (Basel). 2022. PMID: 35205810 Free PMC article.
-
Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway.Oncol Lett. 2021 Dec;22(6):835. doi: 10.3892/ol.2021.13096. Epub 2021 Oct 15. Oncol Lett. 2021. PMID: 34712359 Free PMC article.
-
Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma.Front Oncol. 2021 Apr 28;11:643065. doi: 10.3389/fonc.2021.643065. eCollection 2021. Front Oncol. 2021. PMID: 33996558 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous